St. Jude Medical's heart devices get FDA approval

09/18/2007 | Star Tribune (Minneapolis-St. Paul, Minn.)

The FDA has approved St. Jude Medical's Promote cardiac resynchronization therapy defibrillator and Current implantable cardioverter defibrillator. The products, which will be unveiled at a heart association meeting in November, are radiofrequency wireless devices designed to treat patients with heart failure and heart arrhythmias.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR